Skip to main content
Article
Mortality after the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study
Schizophrenia Bulletin
  • Paul Kurdyak, Centre for Addiction and Mental Health
  • Emilie Mallia, Centre for Addiction and Mental Health
  • Claire De Oliveira, Centre for Addiction and Mental Health
  • Andre F. Carvalho, Centre for Addiction and Mental Health
  • Nicole Kozloff, Centre for Addiction and Mental Health
  • Juveria Zaheer, Centre for Addiction and Mental Health
  • Wanda M. Tempelaar, Centre for Addiction and Mental Health
  • Kelly K. Anderson, Institute for Clinical Evaluative Sciences
  • Christoph U. Correll, The Zucker Hillside Hospital
  • Aristotle N. Voineskos, Centre for Addiction and Mental Health
Document Type
Article
Publication Date
5-1-2021
URL with Digital Object Identifier
10.1093/schbul/sbaa180
Abstract

There is emerging evidence of high mortality rates after the first diagnosis of psychotic disorder. The objective of this study was to estimate the standardized mortality ratio (SMR) in a population-based cohort of individuals with a first diagnosis of schizophrenia-spectrum psychotic disorder (SSD). The cohort included a population-based sample of individuals with a first diagnosis of SSD based on the first diagnosis occurring during hospitalization or in an outpatient setting between 2007 and 2010 in Ontario, Canada. All patients were followed for 5 years after the first diagnosis. The primary outcome was SMR, including all-cause, suicide-related, accidental, and other causes. Between 2007 and 2010, there were 2382 patients in the hospitalization cohort and 11 003 patients in the outpatient cohort. Over the 5-year observation period, 97 (4.1%) of the hospitalization cohort and 292 (2.7%) of the outpatient cohort died, resulting in an SMR of 13.6 and 9.1, respectively. In both cohorts, suicide was the most common cause of death. Approximately 1 in 25 patients with a first diagnosis of SSD during hospitalization, and 1 in 40 patients with a first diagnosis of SSD in an outpatient setting, died within 5 years of first diagnosis in Ontario, Canada. This mortality rate is between 9 and 13 times higher than would be expected in the age-matched general population. Based on these data, timely access to services should be a public health priority to reduce mortality following a first diagnosis of an SSD.

Citation Information
Paul Kurdyak, Emilie Mallia, Claire De Oliveira, Andre F. Carvalho, et al.. "Mortality after the First Diagnosis of Schizophrenia-Spectrum Disorders: A Population-based Retrospective Cohort Study" Schizophrenia Bulletin Vol. 47 Iss. 3 (2021) p. 864 - 874
Available at: http://works.bepress.com/kelly-anderson/27/